Health policy
-

Dr. Chowdhury is a vascular surgeon and pioneering public health leader from Bangladesh who wrote "The Politics of Essential Drugs: The Makings of a Successful Health Strategy: Lessons from Bangladesh." In 1971, Dr. Chowdhury left England to return to what was then East Pakistan and join the war of liberation for Bangladesh. He helped establish a field hospital for freedom fighters and refugees, which lead to the development Gonoshasthaya Kendra (GK) or "The People's Health Center." GK has trained more than 7,000 barefoot doctors, and serves 1,000 villages in 14 Bangladeshi districts. A pharmaceutical factory was established by GK in 1981 which produces medicines on the World Health Organization's essential medicines list; employs 1,500 people and has an $11 million annual budget. One-half of its profits are reinvested and the other half go to GK's other projects. In 1985, Dr. Chowdhury and GK were awarded the Ramon Magsaysay Award (sometimes called the Asian Nobel Peace Prize) and in 1992, the Right Livelihood Award (also known as the alternative Nobel Prize). Dr. Chowdhury was instrumental in convincing the Bangladesh government to adopt a National Drug Policy in 1982. This controversial policy promotes essential medicines and discourages the use of drugs with little therapeutic value. GK hosted the People's Health Assembly in December 2000, which challenged global health organizations to improve public health care for the poor. Dr. Chowdhury is this year's International Honoree of the UC Berkeley School of Public Health Heroes.

Philippines Conference Room

Dr. Zafrullah Chowdury Vascular Surgeon Speaker The People's Health Center, Bangladesh
Seminars
-

Korea achieved national health insurance coverage for the entire population in 1989, thirteen years after Korea adopted a national health insurance policy. Its success drew a lot of attention from other countries, including the US. This talk will explain the secrets of its success and also critique the pitfall of its national health insurance system. However, more recently, Korea has faced challenges from most parts of its health care system. The national health insurance corporation has been showing financial deficits. Also, the health care delivery sector has experienced a series of political battles among professional groups: physician vs. pharmacist, and oriental medical doctors vs. pharmacists. The seminar will analyze the reasons for these challenges, and discuss the direction for Korea's health care reforms. Those who have interests in the Korean national health insurance systems, please refer to Gerard Anderson (1989) "Universal Health Care Coverage in Korea." Health Affairs, Summer ,24-35. Miron Stano (1990) "Comparing US and Korean Health Care." Health Affairs, Summer, 237-238. Those who have interests in the political battles among professional groups, please refer to Hoy-Je Cho, (2000) "Traditional Medicine, Professional Monopoly and Structural Interests: a Korean Case." Social Science & Medicine, Vol 50, Issue 1, 123-135. These articles can be downloaded from the Stanford e-journal lists. This program is free and open to the public. Lunch will be provided for those who RSVP before noon on Wednesday, Novermber 28 to Okky Choi. Tel: (650) 724-8271 or Email: okkychoi@stanford.edu

Encina Hall, Central Wing, third floor, Philippines Conference Room

Ki-Taig Jung Visiting Professor , Stanford Center for Health Policy Speaker MD MBA Program, Kyung Hee University, Seoul Korea
Seminars
Paragraphs

On May 4 and 5, 2000, health care leaders, professionals, and academics convened at the Bechtel Conference Center at Stanford University for the Health Care Conference 2000. Sponsored by the Comparative Health Care Policy Research Project at the Asia/Pacific Research Center (Shorenstein APARC), in cooperation with the Center for Health Policy (CHP), the conference was held for the purpose of discussing health care policies and issues facing nations today. With the pressures of rising costs, aging populations in industrialized countries, and rapid technological advancements, the need for an accessible, affordable, and effective health care system is urgent and greater than ever. The first conference of its kind at Shorenstein APARC, the Health Care Conference 2000 established a forum for candid discussion about the past, present, and future of health care. Over sixty participants attended the conference. The panel consisted of speakers from governmental institutions, for-profit and nonprofit organizations, universities, and research institutes. The first day of the conference featured a discussion on the evolution of the health care market in the United States, while the second day focused on the effects of market forces overseas, specifically in England, Japan, the Netherlands, New Zealand, Scotland, and Singapore. The 1990s marked an era of major health care reform. For many nations with socialized health care systems, it was a decade to explore alternative systems and to move toward privatization. The implications of such changes were discussed in detail at the conference. The Health Care Conference 2000 was a successful and informative meeting, which opened the doors for future discussions on issues concerning health care around the world. These proceedings present, in edited form, the remarks of all primary conference speakers. Please contact Shorenstein APARC if you have any questions about the conference, or about the Center's work in general.

All Publications button
1
Publication Type
Working Papers
Publication Date
Journal Publisher
Shorenstein APARC
Authors
Number
ISBN: 1-931368-01-5

The Comparative Health Care Policy Research Project was initiated by APARC in 1990 to examine issues related to the structure and delivery of health care in Japan by utilizing contemporary social science. Further, the project was designed to make the study of Japan an integral part of international comparative health policy research. Yumiko Nishimura, the associate director, under the supervision of Daniel I. Okimoto, the principal investigator, leads the project.

Paragraphs

Hysterectomy is the most common non-pregnancy-related major surgery performed on women in the United States. Close to 600,000 women in the United States undergo the procedure each year, with annual costs exceeding $5 billion. By age 60, more than one-third of women in the United States have had a hysterectomy.

Many believe that the high U.S. hysterectomy rate is a result of an expansion of the accepted indications for hysterectomy. More reasons are listed for removal of the uterus than for any other organ, with indications ranging from life-threatening cancer of the genital tract to menstrual pain. In the United States, hysterectomy is widely accepted by medical professionals and by the public as an appropriate treatment for uterine cancer and for various common non-cancerous uterine conditions that produce disabling levels of pain, discomfort, uterine bleeding, emotional distress, and related symptoms.

With so many possible indications for hysterectomy, the decision as to when to perform the procedure may be a great contributing factor in the different rates of hysterectomy between countries. This study poses the question, "Does individual physician decision-making affect hysterectomy rates in different countries?"

All Publications button
1
Publication Type
Working Papers
Publication Date
Journal Publisher
Shorenstein APARC
Authors
Subscribe to Health policy